Electroporation Therapies: Clinical Trials

4 trials of Electroporation Therapies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 1, Withdrawn 1
Phase 22Completed 1, Terminated 1

Follow Electroporation Therapies: new trials by email Literature Review of Electroporation Therapies trials Research Report on Electroporation Therapies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat
ImmunoPulse, Epacadostat, Pembrolizumab - Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2TerminatedChase Heaton, MD142019-05-022023-05-09
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions
Electroporation, HPV DNA Plasmids Therapeutic Vaccine VGX-3100, Laboratory Biomarker Analysis - Anal Intraepithelial Neoplasia, High Grade Squamous Intraepithelial Neoplasia
Phase 2CompletedAIDS Malignancy Consortium442018-09-212026-07-08
Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer
bleomycin sulfate, electroporation therapy - Pancreatic Cancer
Phase 1WithdrawnIchor Medical Systems Incorporated2000-12-012012-09-19
Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
bleomycin sulfate, electroporation therapy - Melanoma (Skin)
Phase 1UnknownH. Lee Moffitt Cancer Center and Research Institute2000-06-012013-09-17

Conditions studied

HIV Seropositivity (1)  ·  Melanoma (1)  ·  Pancreatic Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Squamous Intraepithelial Lesions (1)

Sponsors

AIDS Malignancy Consortium (1)  ·  Chase Heaton, MD (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Ichor Medical Systems Incorporated (1)

Countries

United States (3)  ·  Puerto Rico (1)

Top investigators

Chase Heaton, MD (1)  ·  Richard C. Karl, MD (1)  ·  Ronald C. DeConti, MD (1)

NIH funding

UM1CA121947 (1)